Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced diagnostic tools aimed at expanding precision medicine. Leveraging DHR’s newly...

VISTA, California, April 25, 2025 – Leica Biosystems is pleased to announce the debut of its latest digital pathology innovation, the Aperio FL digital system, at the American Association of Cancer Researchers (AACR) Annual Meeting in...

AUSTIN, Texas (March 27, 2025) – Clinical laboratory and pathology executives from many of the nation’s most-prominent clinical labs will come together on April 28-30, 2025 in New Orleans, LA, to celebrate the 30th anniversary the...

Join Leica Biosystems and NEO Genomics for next week's webinar. Optimization of IHC & digital pathology workflows in the development of novel therapeutic ADCs Date: March 5, 2025 Time: 8:00 AM (PT), 11:00 AM (ET) REGISTER...

January 17, 2025 - VISTA, CA – Building on 25 years of leading innovation, we are excited to unveil the latest groundbreaking advancements for our Aperio GT 450 Digital Pathology Scanner The Aperio GT 450 scanner’s proven technology,...

Leica Biosystems and Indica Labs: Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical...